Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis: A Randomized Clinical Trial

Creators: Cohen, Jeffrey; Belova, Anna; Selmaj, Krzysztof; Wolf, Christian; SORMANI, MARIA PIA; Oberyé, Janine; van den Tweel, Evelyn; Mulder, Roel; Koper, Norbert; Voortman, Gerrit; Barkhof, Frederik; Giovannoni, G; Radul, E. W; Volp, A.

Others:: Cohen, Jeffrey; Belova, Anna; Selmaj, Krzysztof; Wolf, Christian; Sormani, MARIA PIA; Oberyé, Janine; van den Tweel, Evelyn; Mulder, Roel; Koper, Norbert; Voortman, Gerrit; Barkhof, Frederik; Giovannoni, G; Radul, E. W; Volp, A.

Description

The patents for the first approved treatments for relapsing-remitting multiple sclerosis are expiring, creating the opportunity to develop generic alternatives.

Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis: A Randomized Clinical Trial

Description

Additional details